In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Bayer getting out of prescription dermatology, selling business to Leo Pharma

Executive Summary

Bayer AG sold Leo Pharma AS its global prescription dermatology business, including 450 employees. (The business is assumed to be the former Intendis division, later renamed Dermatology Inc. and absorbed into Bayer HealthCare LLC.) The deal excludes rights to the products in Afghanistan and Pakistan. Bayer’s OTC dermatology portfolio (which contains Bepanthen, Canesten, and others) is also not part of the agreement.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
Deal Status
  • Final
Deal Type
  • Acquisition
    • Divestiture/Spin-Out

Related Companies